|
EPA/DHA 1:1
|
EPA/DHA 2:1
|
EPA/DHA 1:2
|
Soybean oil
|
Linseed oil
|
---|
Biomarkers
|
Mean ± SD
|
Mean ± SD
|
Mean ± SD
|
p
|
Mean ± SD
|
P
|
Mean ± SD
|
p
|
---|
CVD RISK MARKERS
|
---|
Inflammation
|
CRP (μg/mL)
|
147.0 ± 20.5
|
147.1 ± 22.4
|
140.1 ± 52.7
| |
172.9 ± 38.2
| |
142.9 ± 52.0
| |
Thrombotic activity
|
PAI-1 (μg/mL)
|
7.48 ± 1.3
|
8.75 ± 1.8
|
9.18 ± 1.3
| |
6.45 ± 0.8
|
c0.030
|
7.76 ± 1.1
| |
Endothelial dysfunction
|
sVCAM (μg/mL)
|
3.41 ± 0.7
|
3.01 ± 0.4
|
4.40 ± 1.3
|
b0.046
|
3.36 ± 1.7
| |
2.10 ± 0.4
|
a0.001
|
| | | | | | |
b0.001
|
| | | | | | |
c0.003
|
sICAM (ng/mL)
|
0.59 ± 0.2
|
0.61 ± 0.2
|
0.53 ± 0.2
| |
0.52 ± 0.1
| |
0.59 ± 0.3
| |
- The data are expressed as mean ± SD (standard deviation). a: differences with respect to EPA/DHA 1:1 supplementation; b: differences with respect to EPA/DHA 2:1 supplementation; c: differences with respect to EPA/DHA 1:2 supplementation.